IPATASERTIB: 125 Adverse Event Reports & Safety Profile
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
125
Total FAERS Reports
20 (16.0%)
Deaths Reported
95
Hospitalizations
125
As Primary/Secondary Suspect
3
Life-Threatening
1
Disabilities
First Report: 20110804 · Latest Report: 20241202
What Are the Most Common IPATASERTIB Side Effects?
#1 Most Reported
Diarrhoea
17 reports (13.6%)
#2 Most Reported
Pyrexia
11 reports (8.8%)
#3 Most Reported
Fatigue
10 reports (8.0%)
All IPATASERTIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 17 | 13.6% | 4 | 11 |
| Pyrexia | 11 | 8.8% | 0 | 10 |
| Fatigue | 10 | 8.0% | 1 | 5 |
| Hyperglycaemia | 9 | 7.2% | 3 | 5 |
| Rash | 8 | 6.4% | 2 | 4 |
| Nausea | 7 | 5.6% | 2 | 2 |
| Vomiting | 7 | 5.6% | 2 | 3 |
| Acute kidney injury | 6 | 4.8% | 0 | 6 |
| Pneumonitis | 6 | 4.8% | 1 | 2 |
| Rash maculo-papular | 6 | 4.8% | 0 | 4 |
| Anaemia | 5 | 4.0% | 2 | 2 |
| Dehydration | 5 | 4.0% | 0 | 5 |
| Drug ineffective | 5 | 4.0% | 0 | 1 |
Who Reports IPATASERTIB Side Effects? Age & Gender Data
Gender: 57.0% female, 43.0% male. Average age: 61.7 years. Most reports from: US. View detailed demographics →
Is IPATASERTIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 0 |
| 2014 | 11 | 2 | 9 |
| 2015 | 3 | 2 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 13 | 2 | 12 |
| 2019 | 24 | 1 | 22 |
| 2020 | 23 | 7 | 21 |
| 2021 | 7 | 0 | 4 |
| 2022 | 13 | 1 | 12 |
| 2023 | 2 | 0 | 2 |
| 2024 | 2 | 0 | 1 |
What Is IPATASERTIB Used For?
| Indication | Reports |
|---|---|
| Triple negative breast cancer | 26 |
| Breast cancer | 17 |
| Hormone-refractory prostate cancer | 14 |
| Prostate cancer | 11 |
| Breast cancer metastatic | 9 |
| Prostate cancer metastatic | 8 |
| Her2 negative breast cancer | 7 |
| Neoplasm | 7 |
IPATASERTIB vs Alternatives: Which Is Safer?
IPATASERTIB vs IPILIMUMAB
IPATASERTIB vs IPRAGLIFLOZIN L-PROLINE
IPATASERTIB vs IPRATROPIUM
IPATASERTIB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPATASERTIB vs IPTACOPAN
IPATASERTIB vs IRBESARTAN
IPATASERTIB vs IRINOTECAN
IPATASERTIB vs IRON
IPATASERTIB vs IRON DEXTRAN
IPATASERTIB vs IRON ISOMALTOSIDE 1000
Official FDA Label for IPATASERTIB
Official prescribing information from the FDA-approved drug label.